Alloreactive Donor Lymphocytes Infusions for relapse after HLA-identical myeloablative allogeneic hematopoietic stem cell transplantation (HSCT): Ten years long-term follow-up and outcome.

被引:0
|
作者
Michallet, ASAS
Nicolini, FFE
Tremisi, JPJP
Dubois, VV
Hayette, SS
Vigouroux, CC
Bourgeot, JPJP
Thomas, XX
Gebuhrer, LL
Michallet, MM
机构
[1] Hop Edouard Herriot, Hematol Lab, Lyon, France
[2] EFS, Histocompatibil Lab, Lyon, France
[3] EFS, Ctr Sante, Lyon, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5601
引用
收藏
页码:469B / 469B
页数:1
相关论文
共 50 条
  • [31] Long-Term Follow-up of AML Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation after Primary Induction Failure
    Jovein, Miriam Mozaffari
    Ihorst, Gabriele
    Afonso, Jesus Duque
    Waesch, Ralph
    Wehr, Claudia
    Bertz, Hartmut
    Duyster, Justus
    Zeiser, Robert
    Finke, Juergen
    Scherer, Florian
    BLOOD, 2023, 142
  • [32] Global longitudinal strain is superior to ejection fraction for long-term follow-up after allogeneic hematopoietic stem cell transplantation
    Watanabe, Marika
    Yakushijin, Kimikazu
    Tanaka, Hidekazu
    Chijiki, Ruri
    Saeki, Miki
    Hirakawa, Yuri
    Takakura, Hidetomo
    Usui, Yutaro
    Ichikawa, Hiroya
    Sakai, Rina
    Matsumoto, Sakuya
    Nagao, Shigeki
    Mizutani, Yu
    Kurata, Keiji
    Kitao, Akihito
    Miyata, Yoshiharu
    Saito, Yasuyuki
    Kawamoto, Shinichiro
    Yamamoto, Katsuya
    Ito, Mitsuhiro
    Matsuoka, Hiroshi
    Minami, Hironobu
    EJHAEM, 2023, 4 (01): : 192 - 198
  • [33] Global Longitudinal Strain Is Superior to Ejection Fraction for Long-Term Follow-up after Allogeneic Hematopoietic Stem Cell Transplantation
    Watanabe, Marika
    Yakushijin, Kimikazu
    Tanaka, Hidekazu
    Chijiki, Ruri
    Saeki, Miki
    Hirakawa, Yuri
    Takakura, Hidetomo
    Usui, Yutaro
    Sakai, Rina
    Matsumoto, Sakuya
    Mizutani, Yu
    Kitao, Akihito
    Nagao, Shigeki
    Miyata, Yoshiharu
    Saito, Yasuyuki
    Kawamoto, Shinichiro
    Yamamoto, Katsuya
    Ito, Mitsuhiro
    Matsuoka, Hiroshi
    Minami, Hironobu
    BLOOD, 2021, 138 : 1824 - +
  • [34] Physical Fitness and Frailty in Males after Allogeneic Hematopoietic Stem Cell Transplantation in Childhood: A Long-Term Follow-Up Study
    Suominen, Anu
    Haavisto, Anu
    Mathiesen, Sidsel
    Mejdahl Nielsen, Malene
    Lahteenmaki, Paivi M.
    Sorensen, Kaspar
    Ifversen, Marianne
    Molgaard, Christian
    Juul, Anders
    Muller, Klaus
    Jahnukainen, Kirsi
    CANCERS, 2022, 14 (14)
  • [35] Long-Term Outcome After Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Montefusco, V.
    Peccatori, J.
    Grifoni, F.
    Spina, F.
    Olivieri, A.
    Farina, L.
    Dodero, A.
    Milani, R.
    Onida, F.
    Ciceri, F.
    Corradini, P.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S46 - S46
  • [36] First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
    Kuskonmaz, Baris
    Ayvaz, Deniz
    Okur, Fatma Visal
    Aydin, Burca
    Tezcan, Ilhan
    Uckan Cetinkaya, Duygu
    BONE MARROW TRANSPLANTATION, 2022, 57 (07) : 1210 - 1212
  • [37] First allogeneic hematopoietic stem cell transplantation in RASGRP1 deficiency: long-term follow-up
    Baris Kuskonmaz
    Deniz Ayvaz
    Fatma Visal Okur
    Burça Aydın
    Ilhan Tezcan
    Duygu Uckan Cetinkaya
    Bone Marrow Transplantation, 2022, 57 : 1210 - 1212
  • [38] Long-Term Follow-up of Patients With Multiple Myeloma Who Received Allogeneic Hematopoietic Stem Cell Transplantation
    Donato, Michele L.
    Siegel, David S.
    Vesole, David H.
    McKiernan, Phyllis
    Nyirenda, Themba
    Baker, Melissa
    Mato, Anthony
    Richter, Joshua R.
    Pecora, Andrew L.
    Rowley, Scott D.
    BLOOD, 2013, 122 (21)
  • [39] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
    Shimoni, A.
    Hardan, I.
    Shem-Tov, N.
    Yerushalmi, R.
    Nagler, A.
    LEUKEMIA, 2010, 24 (05) : 1050 - 1052
  • [40] Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
    A Shimoni
    I Hardan
    N Shem-Tov
    R Yerushalmi
    A Nagler
    Leukemia, 2010, 24 : 1050 - 1052